UC Davis Researchers Awarded $28M to Combat Rift Valley Fever
Researchers at the University of California, Davis, One Health Institute, or OHI, have been awarded $28 million to lead a novel human vaccine trial against Rift Valley fever virus in Africa. The project, funded by the Coalition for Epidemic Preparedness Innovations, or CEPI, and the European Union’s Horizon Europe program, aims to work with partners in African countries affected by the virus to assess the safety and immune response of the vaccine in people most at risk.
Source: ucdavis.edu